Results 331 to 340 of about 1,594,004 (375)
Author Correction: AAV-based delivery of RNAi targeting ataxin-2 improves survival and pathology in TDP-43 mice. [PDF]
Amado DA +14 more
europepmc +1 more source
BOS172738, a selective RET inhibitor, for the treatment of patients with RET-altered tumors including RET-fusion-positive non-small-cell lung cancer and RET-mutant medullary thyroid cancer: a phase I dose-escalation/expansion multicenter study. [PDF]
Schöffski P +12 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Nucleic Acid Therapeutics: Successes, Milestones, and Upcoming Innovation.
Nucleic Acid TherapeuticsNucleic acid-based therapies have become the third major drug class after small molecules and antibodies. The role of nucleic acid-based therapies has been strengthened by recent regulatory approvals and tremendous clinical success.
Jillian Belgrad +2 more
semanticscholar +1 more source
Therapeutic Communities: A Therapeutic Bridge
Journal of Psychoactive Drugs, 2004The original therapeutic community movement has seen a variety of interpretations that may bear little resemblance to the original model. The democratic model concept of social learning offers one approach to further social maturation and personality change.
openaire +2 more sources
mRNA-based cancer therapeutics
Nature Reviews. Cancer, 2023Chuang Liu +5 more
semanticscholar +1 more source
An overview of microRNAs: Biology, functions, therapeutics, and analysis methods
Journal of Cellular Physiology, 2018MicroRNAs (miRNAs) are a class of small noncoding RNAs, which function in posttranscriptional regulation of gene expression. They are powerful regulators of various cellular activities including cell growth, differentiation, development, and apoptosis ...
K. Saliminejad +3 more
semanticscholar +1 more source

